COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR MODULATING CHROMOPHORUS FLOW IN A RETINOID CYCLE, TREATING A DISEASE OR DISHALM IN AN INDIVIDUAL TO INHIBIT DARK ADAPTATION TO THE FAST RAPIDINA CELL REGULINA RETINAL BOD POTORECEPTOR CELL, TO REDUCE ISCHEMIA IN AN EYE OF AN INDIVIDUAL, INHIBIT NEOVASCULARIZATION IN AN EYE OF AN INDIVIDUAL, AND INHIBIT DEGENERATION OF A RETINAL CELL
IAN LESLIE SCOTT,VLADIMIR ALEKSANDROVICH KUKSA,ANNA GALL,MARK W. ORME,JENNIFER GAGE,THOMAS L. LITTLE,QIN JIANG,LANA MICHELE ROSSITER,KEVIN F. MCGEE,RYO KUBOTA
申请号：
BRPI0810063
公开号：
BRPI0810063A2
申请日:
2008.04.21
申请国别(地区):
BR
年份:
2014
代理人:
摘要：
The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
